129 related articles for article (PubMed ID: 6693665)
1. Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoring.
Kemp JP; Chervinsky P; Orgel HA; Meltzer EO; Noyes JH; Mingo TS
J Allergy Clin Immunol; 1984 Jan; 73(1 Pt 1):32-43. PubMed ID: 6693665
[TBL] [Abstract][Full Text] [Related]
2. Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.
Orgel HA; Kemp JP; Tinkelman DG; Webb DR
J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):55-62. PubMed ID: 3968329
[TBL] [Abstract][Full Text] [Related]
3. Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol.
Nathan RA; Bodman SF; Storms WW; Mingo TS
Ann Allergy; 1986 Jun; 56(6):494-9. PubMed ID: 3717716
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of inhaled bitolterol mesylate via metered-dose inhaler in children with asthma.
Bierman CW; Kemp JP; Nathan RA
Ann Allergy Asthma Immunol; 1996 Jan; 76(1):27-35. PubMed ID: 8564625
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bronchodilator responses with bitolterol mesylate solution with the use of two different nebulizer systems in asthma.
Kemp JP; Pinnas JL; Tinkelman DG; Meltzer EO; Campbell SC; Orgel HA; Welch MJ; Mingo TS
J Allergy Clin Immunol; 1986 Mar; 77(3):509-15. PubMed ID: 3950254
[TBL] [Abstract][Full Text] [Related]
6. Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol.
Kemp JP; Orgel HA; Grossman J; Reed CE; Tinkelman DG; Webb DR; Ziment I
Ann Allergy; 1987 Jul; 59(1):17-20. PubMed ID: 3300436
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthma.
Nathan RA; Bernstein IL; Bronsky EA; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Pinnas JL; Repsher LH
J Allergy Clin Immunol; 1987 May; 79(5):822-9. PubMed ID: 3571773
[TBL] [Abstract][Full Text] [Related]
8. Bitolterol mesylate in exercise-induced asthma.
Walker SB; Bierman CW; Pierson WE; Shapiro GG; Furukawa CT; Mingo TS
J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):32-6. PubMed ID: 3944373
[TBL] [Abstract][Full Text] [Related]
9. Effects of the addition of nedocromil sodium to maintenance bronchodilator therapy in the management of chronic asthma.
Callaghan B; Teo NC; Clancy L
Chest; 1992 Mar; 101(3):787-92. PubMed ID: 1311666
[TBL] [Abstract][Full Text] [Related]
10. Bitolterol mesylate (WIN 32784) aerosol. A new long-acting bronchodilator with reduced chronotropic effects.
Kass I; Mingo TS
Chest; 1980 Aug; 78(2):283-7. PubMed ID: 6995040
[TBL] [Abstract][Full Text] [Related]
11. Nocturnal asthma therapy. Inhaled bitolterol versus sustained-release theophylline.
Zwillich CW; Neagley SR; Cicutto L; White DP; Martin RJ
Am Rev Respir Dis; 1989 Feb; 139(2):470-4. PubMed ID: 2643904
[TBL] [Abstract][Full Text] [Related]
12. Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease.
Friedel HA; Brogden RN
Drugs; 1988 Jan; 35(1):22-41. PubMed ID: 3278878
[TBL] [Abstract][Full Text] [Related]
13. Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.
Pinnas JL; Bhatt BD; Campbell SC; Kemp JP; Tinkelman DG
Chest; 1987 Apr; 91(4):533-9. PubMed ID: 3549173
[TBL] [Abstract][Full Text] [Related]
14. Bitolterol mesylate: a beta-adrenergic agent. Chemistry, pharmacokinetics, pharmacodynamics, adverse effects and clinical efficacy in asthma.
Walker SB; Kradjan WA; Bierman CW
Pharmacotherapy; 1985; 5(3):127-37. PubMed ID: 3895171
[TBL] [Abstract][Full Text] [Related]
15. Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.
Nathan RA; Bronsky EA; Dockhorn RJ; Kemp JP
Ann Allergy; 1994 Mar; 72(3):209-16. PubMed ID: 8129213
[TBL] [Abstract][Full Text] [Related]
16. The effects of the combination of inhaled ipratropium and oral theophylline in asthma.
Burki NK
Chest; 1997 Jun; 111(6):1509-13. PubMed ID: 9187165
[TBL] [Abstract][Full Text] [Related]
17. Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects.
Midgren B; Melander B; Persson G
Chest; 1992 Apr; 101(4):1019-22. PubMed ID: 1348219
[TBL] [Abstract][Full Text] [Related]
18. Intervention Studies of Inhaled Corticosteroids Combined with Long-acting Theophylline or Long-acting β
Wang Y; Chen P; Dai A; Shang S; Kong L
Clin Ther; 2016 Dec; 38(12):2622-2627.e1. PubMed ID: 27913032
[TBL] [Abstract][Full Text] [Related]
19. Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group.
Reed CE; Offord KP; Nelson HS; Li JT; Tinkelman DG
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):14-23. PubMed ID: 9449495
[TBL] [Abstract][Full Text] [Related]
20. Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patients.
Pinnas JL; Bernstein IL; Bronsky EE; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Nathan RA; Repsher LH; Bhatt BD
J Allergy Clin Immunol; 1987 May; 79(5):768-75. PubMed ID: 3571768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
